Tufts CSDD: Adoption of AI is High Across Industry

Article

Applied Clinical Trials

The Tufts Center for Drug Development found in a recent analysis that the pharmaceutical industry is adopting artificial intelligence (AI) in numerous ways. 59% of respondents said they plan to expand artificial intelligence staff through 2020. The highest  uses of AI are in clinical operations, safety/risk management, and information technology.

 

For more from the report, click here.

 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.